| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Advance Directives | 22 | 2020 | 33 | 4.660 |
Why?
|
| Withholding Treatment | 17 | 2019 | 30 | 4.650 |
Why?
|
| Defibrillators, Implantable | 16 | 2015 | 39 | 4.350 |
Why?
|
| Pacemaker, Artificial | 11 | 2015 | 18 | 3.650 |
Why?
|
| Terminal Care | 15 | 2017 | 53 | 3.270 |
Why?
|
| Decision Making | 18 | 2020 | 242 | 3.190 |
Why?
|
| Ethics, Medical | 12 | 2018 | 18 | 2.800 |
Why?
|
| Electroconvulsive Therapy | 14 | 2011 | 17 | 2.470 |
Why?
|
| Attitude of Health Personnel | 14 | 2020 | 222 | 2.290 |
Why?
|
| Heart Failure | 11 | 2020 | 298 | 2.100 |
Why?
|
| Palliative Care | 10 | 2020 | 61 | 1.990 |
Why?
|
| Heart-Assist Devices | 7 | 2014 | 37 | 1.690 |
Why?
|
| Humans | 159 | 2020 | 42113 | 1.530 |
Why?
|
| Suicide, Assisted | 4 | 2020 | 7 | 1.460 |
Why?
|
| Mental Competency | 4 | 2019 | 12 | 1.400 |
Why?
|
| Advance Care Planning | 6 | 2020 | 19 | 1.390 |
Why?
|
| Proxy | 5 | 2020 | 7 | 1.380 |
Why?
|
| Aged | 58 | 2019 | 7958 | 1.210 |
Why?
|
| Kidney Failure, Chronic | 4 | 2017 | 239 | 1.200 |
Why?
|
| Education, Medical, Continuing | 7 | 2020 | 35 | 1.190 |
Why?
|
| Physician's Role | 6 | 2013 | 39 | 1.190 |
Why?
|
| Female | 93 | 2020 | 23980 | 1.170 |
Why?
|
| Informed Consent | 6 | 2011 | 34 | 1.150 |
Why?
|
| Aged, 80 and over | 32 | 2019 | 2790 | 1.140 |
Why?
|
| Renal Dialysis | 6 | 2017 | 124 | 1.140 |
Why?
|
| Male | 91 | 2020 | 22745 | 1.110 |
Why?
|
| Patient Satisfaction | 4 | 2017 | 163 | 1.100 |
Why?
|
| Quality of Life | 11 | 2020 | 598 | 1.100 |
Why?
|
| Minnesota | 17 | 2014 | 41 | 1.070 |
Why?
|
| Retrospective Studies | 28 | 2019 | 2466 | 1.060 |
Why?
|
| Internal Medicine | 6 | 2008 | 32 | 1.060 |
Why?
|
| Academic Medical Centers | 6 | 2013 | 73 | 1.020 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2014 | 96 | 0.990 |
Why?
|
| Spirituality | 4 | 2013 | 52 | 0.970 |
Why?
|
| Middle Aged | 66 | 2020 | 11790 | 0.960 |
Why?
|
| Xenopus Proteins | 5 | 2007 | 21 | 0.920 |
Why?
|
| Life Support Care | 4 | 2017 | 8 | 0.920 |
Why?
|
| Attitude to Death | 5 | 2020 | 23 | 0.860 |
Why?
|
| Third-Party Consent | 4 | 2019 | 6 | 0.850 |
Why?
|
| Physician-Patient Relations | 9 | 2017 | 146 | 0.850 |
Why?
|
| Education, Medical, Undergraduate | 4 | 2010 | 93 | 0.840 |
Why?
|
| State Government | 3 | 2019 | 21 | 0.810 |
Why?
|
| United States | 28 | 2019 | 5068 | 0.810 |
Why?
|
| Ethics, Clinical | 3 | 2008 | 5 | 0.800 |
Why?
|
| Patient Education as Topic | 4 | 2013 | 233 | 0.790 |
Why?
|
| Ethicists | 2 | 2013 | 5 | 0.780 |
Why?
|
| Device Removal | 3 | 2013 | 6 | 0.770 |
Why?
|
| Cell Cycle Proteins | 4 | 2007 | 239 | 0.760 |
Why?
|
| Cell Cycle | 6 | 2010 | 348 | 0.760 |
Why?
|
| Awareness | 2 | 2013 | 73 | 0.760 |
Why?
|
| Aortic Valve Stenosis | 3 | 2014 | 33 | 0.750 |
Why?
|
| Attitude to Health | 5 | 2014 | 335 | 0.750 |
Why?
|
| Clinical Clerkship | 3 | 2010 | 27 | 0.730 |
Why?
|
| Comprehension | 3 | 2013 | 40 | 0.720 |
Why?
|
| Adult | 57 | 2020 | 13437 | 0.720 |
Why?
|
| Chaplaincy Service, Hospital | 3 | 2013 | 6 | 0.710 |
Why?
|
| Personal Autonomy | 4 | 2017 | 21 | 0.680 |
Why?
|
| Euthanasia | 1 | 2020 | 3 | 0.680 |
Why?
|
| Delivery of Health Care | 4 | 2013 | 309 | 0.660 |
Why?
|
| Patient Preference | 5 | 2016 | 55 | 0.660 |
Why?
|
| Referral and Consultation | 3 | 2011 | 140 | 0.650 |
Why?
|
| Interdisciplinary Communication | 3 | 2011 | 40 | 0.650 |
Why?
|
| Altruism | 2 | 2011 | 12 | 0.650 |
Why?
|
| Curriculum | 5 | 2012 | 311 | 0.650 |
Why?
|
| Ethics Consultation | 2 | 2013 | 4 | 0.640 |
Why?
|
| Patient Care Team | 5 | 2020 | 57 | 0.640 |
Why?
|
| Morals | 1 | 2020 | 15 | 0.630 |
Why?
|
| Students, Medical | 4 | 2010 | 153 | 0.630 |
Why?
|
| Eating | 3 | 2018 | 164 | 0.630 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 72 | 0.610 |
Why?
|
| Physicians | 5 | 2020 | 180 | 0.610 |
Why?
|
| Government Regulation | 1 | 2019 | 15 | 0.600 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 10 | 0.600 |
Why?
|
| Pastoral Care | 3 | 2010 | 7 | 0.590 |
Why?
|
| Intensive Care Units | 1 | 2019 | 71 | 0.580 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2005 | 139 | 0.580 |
Why?
|
| Xenopus | 5 | 2005 | 47 | 0.570 |
Why?
|
| Wound Healing | 1 | 2019 | 82 | 0.570 |
Why?
|
| Internship and Residency | 8 | 2013 | 141 | 0.560 |
Why?
|
| Schools, Medical | 3 | 2010 | 208 | 0.560 |
Why?
|
| Drinking | 1 | 2018 | 35 | 0.560 |
Why?
|
| Persistent Vegetative State | 2 | 2009 | 2 | 0.550 |
Why?
|
| Drug Industry | 3 | 2008 | 18 | 0.550 |
Why?
|
| Euthanasia, Passive | 2 | 2009 | 3 | 0.550 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 173 | 0.550 |
Why?
|
| Education, Medical | 3 | 2013 | 117 | 0.540 |
Why?
|
| Heart, Artificial | 1 | 2017 | 11 | 0.530 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 8 | 0.530 |
Why?
|
| Patient Compliance | 3 | 2013 | 225 | 0.530 |
Why?
|
| Medical Futility | 3 | 2017 | 10 | 0.510 |
Why?
|
| Ethics Committees | 2 | 2013 | 3 | 0.500 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2016 | 24 | 0.500 |
Why?
|
| Bibliometrics | 2 | 2006 | 15 | 0.490 |
Why?
|
| RNA, Messenger | 2 | 2020 | 1265 | 0.470 |
Why?
|
| Periodicals as Topic | 2 | 2006 | 51 | 0.470 |
Why?
|
| Communication | 5 | 2016 | 207 | 0.470 |
Why?
|
| Critical Illness | 2 | 2013 | 46 | 0.470 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2013 | 42 | 0.470 |
Why?
|
| Clinical Competence | 4 | 2013 | 154 | 0.460 |
Why?
|
| Clinical Medicine | 2 | 2006 | 7 | 0.450 |
Why?
|
| Legal Guardians | 2 | 2011 | 3 | 0.430 |
Why?
|
| Emotions | 2 | 2017 | 251 | 0.430 |
Why?
|
| MicroRNAs | 1 | 2020 | 501 | 0.420 |
Why?
|
| Ethical Analysis | 2 | 2017 | 2 | 0.420 |
Why?
|
| Medical Errors | 1 | 2013 | 6 | 0.410 |
Why?
|
| Patients | 1 | 2013 | 16 | 0.410 |
Why?
|
| Teaching | 5 | 2013 | 58 | 0.410 |
Why?
|
| Biomedical Technology | 1 | 2013 | 9 | 0.410 |
Why?
|
| Cardiology | 1 | 2013 | 18 | 0.400 |
Why?
|
| Tachycardia | 2 | 2010 | 11 | 0.400 |
Why?
|
| Catholicism | 1 | 2013 | 6 | 0.400 |
Why?
|
| Resuscitation Orders | 3 | 2012 | 7 | 0.400 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 1 | 0.390 |
Why?
|
| Vomiting | 2 | 2010 | 14 | 0.390 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 54 | 0.390 |
Why?
|
| Survival Analysis | 6 | 2017 | 362 | 0.390 |
Why?
|
| Professional Competence | 1 | 2013 | 42 | 0.390 |
Why?
|
| Electrocardiography | 3 | 2011 | 183 | 0.380 |
Why?
|
| Hospitalization | 6 | 2013 | 477 | 0.380 |
Why?
|
| Social Values | 2 | 2009 | 31 | 0.370 |
Why?
|
| Depressive Disorder, Major | 4 | 2011 | 128 | 0.370 |
Why?
|
| Depressive Disorder | 6 | 2009 | 185 | 0.370 |
Why?
|
| Philosophy, Medical | 1 | 2011 | 2 | 0.370 |
Why?
|
| Counseling | 1 | 2013 | 134 | 0.360 |
Why?
|
| Fever of Unknown Origin | 2 | 2002 | 7 | 0.360 |
Why?
|
| Allied Health Personnel | 1 | 2011 | 5 | 0.360 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 15 | 0.360 |
Why?
|
| Cooperative Behavior | 2 | 2011 | 250 | 0.350 |
Why?
|
| Faculty, Medical | 3 | 2013 | 74 | 0.350 |
Why?
|
| Nurses | 1 | 2011 | 55 | 0.340 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2010 | 8 | 0.330 |
Why?
|
| Conscious Sedation | 1 | 2010 | 7 | 0.330 |
Why?
|
| International Educational Exchange | 1 | 2010 | 2 | 0.330 |
Why?
|
| Amyloidosis | 4 | 2007 | 38 | 0.330 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 242 | 0.330 |
Why?
|
| Forms and Records Control | 1 | 2010 | 6 | 0.330 |
Why?
|
| Complementary Therapies | 1 | 2010 | 51 | 0.310 |
Why?
|
| Professional-Patient Relations | 1 | 2010 | 59 | 0.310 |
Why?
|
| Edema | 1 | 2009 | 26 | 0.310 |
Why?
|
| Venous Thrombosis | 1 | 2009 | 30 | 0.310 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2009 | 19 | 0.310 |
Why?
|
| Conflict of Interest | 2 | 2013 | 11 | 0.310 |
Why?
|
| Blood Glucose | 13 | 2006 | 386 | 0.310 |
Why?
|
| Calcium Oxalate | 1 | 2009 | 1 | 0.300 |
Why?
|
| Ethylene Glycol | 1 | 2009 | 1 | 0.300 |
Why?
|
| Enteral Nutrition | 2 | 2005 | 17 | 0.290 |
Why?
|
| Medical History Taking | 2 | 2006 | 37 | 0.290 |
Why?
|
| Mental Health | 3 | 2020 | 363 | 0.290 |
Why?
|
| Electric Countershock | 1 | 2008 | 12 | 0.280 |
Why?
|
| Living Donors | 1 | 2008 | 18 | 0.280 |
Why?
|
| Bioethics | 1 | 2008 | 9 | 0.280 |
Why?
|
| Industry | 1 | 2008 | 30 | 0.280 |
Why?
|
| Holistic Health | 2 | 2013 | 13 | 0.280 |
Why?
|
| Office Visits | 1 | 2008 | 28 | 0.280 |
Why?
|
| Catatonia | 1 | 2007 | 1 | 0.280 |
Why?
|
| Ethics, Research | 1 | 2008 | 18 | 0.280 |
Why?
|
| Societies, Medical | 1 | 2008 | 74 | 0.280 |
Why?
|
| Education, Medical, Graduate | 2 | 2010 | 61 | 0.270 |
Why?
|
| Disinfectants | 1 | 2007 | 8 | 0.270 |
Why?
|
| Muscular Diseases | 2 | 2006 | 22 | 0.270 |
Why?
|
| Hospital Records | 1 | 2007 | 4 | 0.270 |
Why?
|
| Tissue and Organ Procurement | 1 | 2008 | 56 | 0.270 |
Why?
|
| Abdominal Pain | 2 | 2006 | 25 | 0.260 |
Why?
|
| Training Support | 1 | 2007 | 8 | 0.260 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 2007 | 1 | 0.260 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 102 | 0.260 |
Why?
|
| Health Personnel | 2 | 2016 | 262 | 0.260 |
Why?
|
| Mesoderm | 2 | 2004 | 73 | 0.260 |
Why?
|
| Embryo, Nonmammalian | 2 | 2004 | 59 | 0.250 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 130 | 0.250 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2007 | 20 | 0.250 |
Why?
|
| Severity of Illness Index | 4 | 2011 | 704 | 0.250 |
Why?
|
| Patient Care | 1 | 2006 | 31 | 0.250 |
Why?
|
| Journalism, Medical | 1 | 2006 | 5 | 0.250 |
Why?
|
| Pain | 1 | 2009 | 283 | 0.250 |
Why?
|
| Self-Evaluation Programs | 1 | 2006 | 2 | 0.250 |
Why?
|
| Deglutition Disorders | 1 | 2007 | 24 | 0.250 |
Why?
|
| Clinical Trials as Topic | 5 | 2008 | 249 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2013 | 467 | 0.250 |
Why?
|
| Health Care Surveys | 4 | 2008 | 152 | 0.250 |
Why?
|
| CDC2 Protein Kinase | 2 | 2005 | 20 | 0.250 |
Why?
|
| Treatment Refusal | 4 | 2017 | 23 | 0.250 |
Why?
|
| Rectus Abdominis | 1 | 2006 | 2 | 0.250 |
Why?
|
| Hematoma | 1 | 2006 | 15 | 0.240 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 287 | 0.240 |
Why?
|
| Aging | 1 | 2011 | 763 | 0.240 |
Why?
|
| Enterococcus faecalis | 1 | 2007 | 44 | 0.240 |
Why?
|
| Heart Rate | 4 | 2011 | 260 | 0.240 |
Why?
|
| Professional Role | 3 | 2013 | 40 | 0.240 |
Why?
|
| History, 19th Century | 3 | 2011 | 26 | 0.240 |
Why?
|
| Publishing | 1 | 2006 | 28 | 0.240 |
Why?
|
| Confidentiality | 3 | 2013 | 27 | 0.240 |
Why?
|
| Problem-Based Learning | 1 | 2006 | 41 | 0.240 |
Why?
|
| Treatment Outcome | 9 | 2020 | 1582 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 357 | 0.230 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 89 | 0.230 |
Why?
|
| Safety | 5 | 2009 | 51 | 0.230 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 2005 | 1 | 0.230 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 183 | 0.230 |
Why?
|
| History, 20th Century | 3 | 2011 | 124 | 0.230 |
Why?
|
| Ethanol | 1 | 2007 | 221 | 0.230 |
Why?
|
| Myocardial Ischemia | 3 | 2007 | 82 | 0.230 |
Why?
|
| Minority Groups | 1 | 2010 | 663 | 0.230 |
Why?
|
| Biological Products | 1 | 2006 | 91 | 0.220 |
Why?
|
| Pregnancy | 5 | 2019 | 1733 | 0.220 |
Why?
|
| Religion and Medicine | 3 | 2011 | 20 | 0.220 |
Why?
|
| Dietary Supplements | 1 | 2006 | 208 | 0.220 |
Why?
|
| Language | 1 | 2006 | 181 | 0.220 |
Why?
|
| Diagnosis, Differential | 5 | 2010 | 236 | 0.220 |
Why?
|
| Depression | 9 | 2007 | 837 | 0.220 |
Why?
|
| Internet | 1 | 2006 | 234 | 0.210 |
Why?
|
| Alcoholism | 1 | 2007 | 292 | 0.210 |
Why?
|
| Cecal Diseases | 1 | 2003 | 2 | 0.210 |
Why?
|
| Blood Pressure | 4 | 2011 | 658 | 0.210 |
Why?
|
| Hospital Departments | 1 | 2003 | 3 | 0.200 |
Why?
|
| Geriatrics | 2 | 2004 | 67 | 0.200 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 479 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2011 | 844 | 0.200 |
Why?
|
| Program Evaluation | 3 | 2012 | 357 | 0.200 |
Why?
|
| Equipment Failure | 2 | 2013 | 12 | 0.200 |
Why?
|
| Data Collection | 4 | 2010 | 210 | 0.190 |
Why?
|
| Asthma | 1 | 2006 | 410 | 0.190 |
Why?
|
| Disclosure | 1 | 2002 | 36 | 0.190 |
Why?
|
| Regenerative Medicine | 2 | 2012 | 10 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2002 | 45 | 0.180 |
Why?
|
| Mental Disorders | 1 | 2006 | 377 | 0.180 |
Why?
|
| Schistosomiasis haematobia | 1 | 2001 | 3 | 0.180 |
Why?
|
| Respiration, Artificial | 3 | 2016 | 46 | 0.180 |
Why?
|
| Embryonic Stem Cells | 2 | 2012 | 55 | 0.180 |
Why?
|
| Young Adult | 7 | 2020 | 4928 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 557 | 0.170 |
Why?
|
| Lymphadenitis | 1 | 2001 | 3 | 0.170 |
Why?
|
| Patient Selection | 4 | 2008 | 192 | 0.170 |
Why?
|
| Age Factors | 6 | 2016 | 1135 | 0.170 |
Why?
|
| Equipment Safety | 2 | 2012 | 5 | 0.170 |
Why?
|
| Emigration and Immigration | 1 | 2001 | 85 | 0.170 |
Why?
|
| Mycobacterium Infections | 1 | 2001 | 16 | 0.170 |
Why?
|
| Mycobacterium | 1 | 2001 | 16 | 0.170 |
Why?
|
| Societies | 1 | 2020 | 6 | 0.170 |
Why?
|
| Anesthesia | 2 | 2011 | 16 | 0.170 |
Why?
|
| Cardiovascular Agents | 2 | 2011 | 24 | 0.170 |
Why?
|
| Prognosis | 5 | 2017 | 847 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2006 | 744 | 0.170 |
Why?
|
| Dental Sac | 1 | 2020 | 1 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 330 | 0.160 |
Why?
|
| Fetus | 2 | 2019 | 101 | 0.160 |
Why?
|
| Motivation | 3 | 2016 | 492 | 0.160 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 522 | 0.160 |
Why?
|
| Insulin | 12 | 2002 | 255 | 0.160 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 79 | 0.160 |
Why?
|
| Adipose Tissue | 2 | 2020 | 180 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2019 | 10 | 0.150 |
Why?
|
| Anesthesia, General | 2 | 2011 | 9 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2000 | 63 | 0.150 |
Why?
|
| Cell Lineage | 1 | 2020 | 104 | 0.150 |
Why?
|
| Prevalence | 3 | 2013 | 1593 | 0.150 |
Why?
|
| Educational Measurement | 2 | 2012 | 100 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2012 | 959 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2010 | 637 | 0.140 |
Why?
|
| Hypotension | 2 | 2008 | 24 | 0.140 |
Why?
|
| Europe | 2 | 2020 | 114 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 683 | 0.140 |
Why?
|
| Coronary Disease | 2 | 2011 | 123 | 0.130 |
Why?
|
| Religion and Psychology | 2 | 2011 | 27 | 0.130 |
Why?
|
| Body Weight | 5 | 2016 | 428 | 0.130 |
Why?
|
| Nutritional Support | 1 | 2016 | 3 | 0.130 |
Why?
|
| Liver Transplantation | 1 | 2017 | 37 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2005 | 973 | 0.130 |
Why?
|
| Research Design | 2 | 2010 | 370 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2020 | 633 | 0.130 |
Why?
|
| Cause of Death | 1 | 2017 | 183 | 0.120 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 1051 | 0.120 |
Why?
|
| Coronary Vessels | 2 | 2007 | 92 | 0.120 |
Why?
|
| Protein Kinases | 2 | 2007 | 100 | 0.120 |
Why?
|
| Thrombocytopenia | 2 | 2008 | 21 | 0.120 |
Why?
|
| Forecasting | 2 | 2019 | 135 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 1221 | 0.110 |
Why?
|
| Spinal Cord Diseases | 2 | 2011 | 5 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 31 | 0.110 |
Why?
|
| Health Surveys | 1 | 2017 | 401 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2015 | 49 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2020 | 722 | 0.110 |
Why?
|
| Mitosis | 3 | 2010 | 112 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2015 | 51 | 0.110 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2014 | 1 | 0.110 |
Why?
|
| Time Factors | 6 | 2019 | 1845 | 0.110 |
Why?
|
| Faith Healing | 2 | 2006 | 4 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 2 | 1985 | 6 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 16 | 0.110 |
Why?
|
| Resuscitation | 1 | 2014 | 22 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2006 | 120 | 0.110 |
Why?
|
| Oocytes | 2 | 2005 | 147 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 236 | 0.110 |
Why?
|
| Coronary Artery Bypass | 2 | 2006 | 47 | 0.100 |
Why?
|
| Codes of Ethics | 1 | 2013 | 1 | 0.100 |
Why?
|
| Physician Impairment | 1 | 2013 | 2 | 0.100 |
Why?
|
| Fatty Acids, Nonesterified | 11 | 1984 | 41 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 570 | 0.100 |
Why?
|
| Overweight | 1 | 2016 | 248 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2007 | 884 | 0.100 |
Why?
|
| Adolescent | 7 | 2010 | 5949 | 0.100 |
Why?
|
| Family | 2 | 2012 | 191 | 0.100 |
Why?
|
| Community Networks | 1 | 2014 | 106 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 38 | 0.100 |
Why?
|
| Total Quality Management | 1 | 2013 | 11 | 0.100 |
Why?
|
| North America | 1 | 2013 | 85 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2013 | 224 | 0.100 |
Why?
|
| Age Distribution | 1 | 2013 | 249 | 0.100 |
Why?
|
| Consumer Product Safety | 1 | 2012 | 10 | 0.100 |
Why?
|
| Thinking | 1 | 2013 | 36 | 0.100 |
Why?
|
| Social Perception | 1 | 2013 | 71 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 162 | 0.100 |
Why?
|
| Animals | 8 | 2010 | 16694 | 0.090 |
Why?
|
| Certification | 1 | 2012 | 21 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 244 | 0.090 |
Why?
|
| Fever | 2 | 2010 | 62 | 0.090 |
Why?
|
| Caregivers | 2 | 2011 | 192 | 0.090 |
Why?
|
| Acute Disease | 2 | 2009 | 156 | 0.090 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2011 | 2 | 0.090 |
Why?
|
| Succinylcholine | 1 | 2011 | 3 | 0.090 |
Why?
|
| Ventricular Premature Complexes | 1 | 2011 | 10 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 17 | 0.090 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2011 | 18 | 0.090 |
Why?
|
| Learning | 1 | 2013 | 155 | 0.090 |
Why?
|
| Anesthetics | 1 | 2011 | 11 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 54 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 30 | 0.090 |
Why?
|
| Conscience | 1 | 2011 | 1 | 0.090 |
Why?
|
| Refusal to Treat | 1 | 2011 | 1 | 0.090 |
Why?
|
| Troponin | 1 | 2011 | 17 | 0.090 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2010 | 10 | 0.090 |
Why?
|
| Survival Rate | 1 | 2012 | 353 | 0.090 |
Why?
|
| Biomedical Enhancement | 1 | 2010 | 1 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 35 | 0.080 |
Why?
|
| Bioethical Issues | 1 | 2010 | 6 | 0.080 |
Why?
|
| Inpatients | 2 | 2011 | 78 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 1188 | 0.080 |
Why?
|
| HIV Infections | 2 | 2003 | 2535 | 0.080 |
Why?
|
| Patient Rights | 1 | 2010 | 1 | 0.080 |
Why?
|
| Teaching Rounds | 1 | 2010 | 4 | 0.080 |
Why?
|
| Neurology | 1 | 2010 | 12 | 0.080 |
Why?
|
| Textbooks as Topic | 1 | 2010 | 3 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2010 | 8 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 1559 | 0.080 |
Why?
|
| Spermatocytes | 1 | 2010 | 27 | 0.080 |
Why?
|
| Substance Abuse Detection | 1 | 2010 | 31 | 0.080 |
Why?
|
| Community Health Services | 1 | 2012 | 207 | 0.080 |
Why?
|
| Spermatids | 1 | 2010 | 42 | 0.080 |
Why?
|
| Arizona | 1 | 2010 | 118 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 3073 | 0.080 |
Why?
|
| Hospitals, Group Practice | 2 | 2007 | 2 | 0.080 |
Why?
|
| Hospital Mortality | 2 | 2012 | 205 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 157 | 0.080 |
Why?
|
| Erythema | 1 | 2009 | 10 | 0.080 |
Why?
|
| Leg | 1 | 2009 | 19 | 0.080 |
Why?
|
| Spermatogonia | 1 | 2010 | 57 | 0.080 |
Why?
|
| Obesity | 2 | 2016 | 1129 | 0.080 |
Why?
|
| Risk Factors | 3 | 2014 | 3933 | 0.080 |
Why?
|
| Interprofessional Relations | 2 | 2007 | 56 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2010 | 110 | 0.070 |
Why?
|
| Seizures | 1 | 2009 | 78 | 0.070 |
Why?
|
| Spermatogenesis | 1 | 2010 | 160 | 0.070 |
Why?
|
| Bradycardia | 1 | 2008 | 9 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 30 | 0.070 |
Why?
|
| Bone Marrow Examination | 1 | 2008 | 1 | 0.070 |
Why?
|
| Confusion | 1 | 2008 | 5 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2008 | 5 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 59 | 0.070 |
Why?
|
| Florida | 1 | 2010 | 461 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2008 | 92 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 23 | 0.070 |
Why?
|
| Dyspnea | 1 | 2008 | 23 | 0.070 |
Why?
|
| Brain Infarction | 1 | 2008 | 22 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2003 | 415 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 224 | 0.070 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.070 |
Why?
|
| Paternalism | 2 | 2012 | 2 | 0.070 |
Why?
|
| Disease Transmission, Infectious | 1 | 2008 | 30 | 0.070 |
Why?
|
| Educational Status | 1 | 2010 | 335 | 0.070 |
Why?
|
| Prednisone | 1 | 2008 | 31 | 0.070 |
Why?
|
| Researcher-Subject Relations | 1 | 2008 | 3 | 0.070 |
Why?
|
| Ethical Review | 1 | 2008 | 3 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 48 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 38 | 0.070 |
Why?
|
| Reimbursement Mechanisms | 1 | 2008 | 11 | 0.070 |
Why?
|
| Cross Infection | 1 | 2008 | 47 | 0.070 |
Why?
|
| Biopsy | 1 | 2008 | 176 | 0.070 |
Why?
|
| Adaptation, Psychological | 3 | 2011 | 410 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 61 | 0.070 |
Why?
|
| 2-Propanol | 1 | 2007 | 4 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 55 | 0.070 |
Why?
|
| Ethics, Dental | 1 | 2007 | 2 | 0.070 |
Why?
|
| Gift Giving | 1 | 2007 | 4 | 0.070 |
Why?
|
| Dentists | 1 | 2007 | 11 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2007 | 87 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 2008 | 89 | 0.070 |
Why?
|
| Religion | 1 | 2008 | 90 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2007 | 15 | 0.070 |
Why?
|
| Ethics Committees, Research | 1 | 2007 | 11 | 0.070 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2007 | 13 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2008 | 90 | 0.070 |
Why?
|
| Hand | 1 | 2007 | 33 | 0.070 |
Why?
|
| Suicide, Attempted | 1 | 2009 | 104 | 0.070 |
Why?
|
| Chronic Disease | 6 | 2005 | 541 | 0.070 |
Why?
|
| Pericardium | 1 | 2007 | 15 | 0.070 |
Why?
|
| Bipolar Disorder | 7 | 1984 | 83 | 0.060 |
Why?
|
| Carbamazepine | 1 | 1986 | 4 | 0.060 |
Why?
|
| Bromocriptine | 2 | 1985 | 6 | 0.060 |
Why?
|
| Baltimore | 1 | 2007 | 58 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2007 | 39 | 0.060 |
Why?
|
| Probability | 1 | 2007 | 82 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2007 | 122 | 0.060 |
Why?
|
| Catalysis | 1 | 2007 | 191 | 0.060 |
Why?
|
| Bacteremia | 1 | 2007 | 37 | 0.060 |
Why?
|
| Psychotic Disorders | 2 | 1986 | 69 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 110 | 0.060 |
Why?
|
| Amyloid | 1 | 2007 | 66 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 928 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 268 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 47 | 0.060 |
Why?
|
| Partial Thromboplastin Time | 1 | 2006 | 9 | 0.060 |
Why?
|
| Trust | 1 | 2008 | 157 | 0.060 |
Why?
|
| Radiography, Abdominal | 1 | 2006 | 7 | 0.060 |
Why?
|
| Online Systems | 1 | 2006 | 5 | 0.060 |
Why?
|
| Databases, Bibliographic | 1 | 2006 | 8 | 0.060 |
Why?
|
| Vaccination | 1 | 2008 | 332 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2006 | 30 | 0.060 |
Why?
|
| Disease Progression | 1 | 2009 | 660 | 0.060 |
Why?
|
| Uncertainty | 1 | 2006 | 32 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 201 | 0.060 |
Why?
|
| Weight Loss | 1 | 2007 | 138 | 0.060 |
Why?
|
| Antipsychotic Agents | 2 | 1985 | 81 | 0.060 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2005 | 4 | 0.060 |
Why?
|
| Gastrostomy | 1 | 2005 | 7 | 0.060 |
Why?
|
| Food Supply | 1 | 2007 | 120 | 0.060 |
Why?
|
| Sex Factors | 2 | 2007 | 1004 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 30 | 0.060 |
Why?
|
| Pancreas | 2 | 2004 | 45 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2006 | 574 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2005 | 22 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 164 | 0.060 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1985 | 2 | 0.060 |
Why?
|
| Puerto Rico | 1 | 2010 | 1376 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2007 | 201 | 0.060 |
Why?
|
| Esophageal Fistula | 1 | 2005 | 1 | 0.060 |
Why?
|
| Lithiasis | 1 | 2005 | 1 | 0.060 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 37 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 206 | 0.060 |
Why?
|
| Bronchial Fistula | 1 | 2005 | 2 | 0.060 |
Why?
|
| Ischemia | 1 | 2006 | 45 | 0.060 |
Why?
|
| Esophagus | 1 | 2006 | 44 | 0.060 |
Why?
|
| Coronary Angiography | 2 | 2008 | 96 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2013 | 1570 | 0.060 |
Why?
|
| Cough | 1 | 2005 | 20 | 0.060 |
Why?
|
| Nausea | 1 | 2005 | 13 | 0.060 |
Why?
|
| Longevity | 2 | 2010 | 167 | 0.060 |
Why?
|
| Long-Term Care | 1 | 2005 | 55 | 0.060 |
Why?
|
| Imino Acids | 1 | 2005 | 1 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 575 | 0.060 |
Why?
|
| Cyclin B | 1 | 2005 | 7 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 1986 | 134 | 0.060 |
Why?
|
| Spodoptera | 1 | 2005 | 17 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1066 | 0.060 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Nickel | 1 | 2005 | 22 | 0.060 |
Why?
|
| DNA Damage | 1 | 2007 | 358 | 0.060 |
Why?
|
| Echocardiography | 2 | 2008 | 167 | 0.060 |
Why?
|
| Quail | 1 | 2004 | 4 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 128 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 728 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2005 | 53 | 0.050 |
Why?
|
| Diarrhea | 1 | 2005 | 95 | 0.050 |
Why?
|
| Glucose | 4 | 1974 | 242 | 0.050 |
Why?
|
| Retinoids | 1 | 2004 | 25 | 0.050 |
Why?
|
| Principle-Based Ethics | 1 | 2004 | 1 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 217 | 0.050 |
Why?
|
| Somites | 1 | 2004 | 2 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2004 | 22 | 0.050 |
Why?
|
| Warfarin | 1 | 2004 | 65 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1058 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2003 | 34 | 0.050 |
Why?
|
| Teaching Materials | 1 | 2003 | 10 | 0.050 |
Why?
|
| Infant | 1 | 2007 | 1142 | 0.050 |
Why?
|
| Glucose Tolerance Test | 6 | 1975 | 76 | 0.050 |
Why?
|
| Limbic Encephalitis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Delirium | 1 | 2002 | 11 | 0.050 |
Why?
|
| Gastrula | 1 | 2002 | 6 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 2002 | 13 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2007 | 1515 | 0.050 |
Why?
|
| Mutation | 1 | 2007 | 1169 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 271 | 0.050 |
Why?
|
| Logistic Models | 3 | 2012 | 1001 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 318 | 0.050 |
Why?
|
| Somalia | 1 | 2001 | 3 | 0.040 |
Why?
|
| Hematuria | 1 | 2001 | 6 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 594 | 0.040 |
Why?
|
| Health Status | 2 | 2020 | 432 | 0.040 |
Why?
|
| Hypertension | 2 | 2007 | 817 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2002 | 60 | 0.040 |
Why?
|
| Amikacin | 1 | 2001 | 3 | 0.040 |
Why?
|
| Models, Biological | 1 | 2004 | 710 | 0.040 |
Why?
|
| Clarithromycin | 1 | 2001 | 9 | 0.040 |
Why?
|
| Exanthema | 1 | 2001 | 12 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 1416 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2001 | 26 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2000 | 7 | 0.040 |
Why?
|
| District of Columbia | 1 | 2020 | 73 | 0.040 |
Why?
|
| Autopsy | 1 | 2000 | 46 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2001 | 73 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 303 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2001 | 178 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 1728 | 0.040 |
Why?
|
| China | 1 | 2020 | 233 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 181 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 53 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2020 | 95 | 0.040 |
Why?
|
| Child | 2 | 2007 | 3381 | 0.040 |
Why?
|
| Inflammation | 1 | 2003 | 729 | 0.040 |
Why?
|
| Schizophrenia | 4 | 1983 | 91 | 0.030 |
Why?
|
| Hospice Care | 1 | 2017 | 20 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2017 | 39 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 512 | 0.030 |
Why?
|
| Syndrome | 3 | 2005 | 73 | 0.030 |
Why?
|
| Growth Hormone | 7 | 1973 | 35 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2004 | 2111 | 0.030 |
Why?
|
| Epinephrine | 1 | 1974 | 37 | 0.030 |
Why?
|
| Fatty Acids | 3 | 1964 | 134 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2013 | 15 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 1970 | 55 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 58 | 0.020 |
Why?
|
| Liability, Legal | 1 | 2012 | 5 | 0.020 |
Why?
|
| Tuberculoma | 1 | 1992 | 1 | 0.020 |
Why?
|
| Perception | 1 | 2014 | 209 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 427 | 0.020 |
Why?
|
| Beneficence | 1 | 2012 | 2 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 157 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 37 | 0.020 |
Why?
|
| Politics | 1 | 2012 | 42 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 190 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 158 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 10 | 0.020 |
Why?
|
| Amitriptyline | 4 | 1973 | 9 | 0.020 |
Why?
|
| Troponin I | 1 | 2011 | 18 | 0.020 |
Why?
|
| Lawyers | 1 | 2010 | 2 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 113 | 0.020 |
Why?
|
| Lithium | 1 | 1970 | 30 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 584 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2011 | 69 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 107 | 0.020 |
Why?
|
| Amino Acids | 4 | 1984 | 150 | 0.020 |
Why?
|
| Defense Mechanisms | 1 | 1970 | 10 | 0.020 |
Why?
|
| Meiosis | 1 | 2010 | 65 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 2010 | 128 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2010 | 91 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 143 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 437 | 0.020 |
Why?
|
| Faculty | 1 | 2010 | 105 | 0.020 |
Why?
|
| Patient Participation | 1 | 2010 | 87 | 0.020 |
Why?
|
| Personality | 1 | 1970 | 55 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1970 | 140 | 0.020 |
Why?
|
| Insulin Resistance | 5 | 1973 | 199 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2002 | 280 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 733 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 649 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 1971 | 205 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1019 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 26 | 0.020 |
Why?
|
| Achievement | 1 | 2008 | 24 | 0.020 |
Why?
|
| Health Facilities | 1 | 2008 | 32 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 4 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 253 | 0.020 |
Why?
|
| Social Support | 1 | 2011 | 437 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 55 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 92 | 0.020 |
Why?
|
| Dentist-Patient Relations | 1 | 2007 | 1 | 0.020 |
Why?
|
| Economics, Dental | 1 | 2007 | 1 | 0.020 |
Why?
|
| General Practice, Dental | 1 | 2007 | 2 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 137 | 0.020 |
Why?
|
| Financial Support | 1 | 2007 | 7 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2007 | 10 | 0.020 |
Why?
|
| Vasa Vasorum | 1 | 2007 | 3 | 0.020 |
Why?
|
| Peer Group | 1 | 2008 | 173 | 0.020 |
Why?
|
| Lipids | 2 | 1970 | 256 | 0.020 |
Why?
|
| Health Policy | 1 | 2008 | 184 | 0.020 |
Why?
|
| Parents | 1 | 2010 | 359 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2006 | 33 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2006 | 7 | 0.020 |
Why?
|
| Stroke | 1 | 2010 | 336 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2005 | 9 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2005 | 20 | 0.010 |
Why?
|
| Necrosis | 1 | 2006 | 54 | 0.010 |
Why?
|
| Bronchial Diseases | 1 | 2005 | 1 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 1976 | 13 | 0.010 |
Why?
|
| Antiparkinson Agents | 1 | 1985 | 14 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2005 | 7 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2005 | 47 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 1985 | 30 | 0.010 |
Why?
|
| International Normalized Ratio | 1 | 2004 | 9 | 0.010 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 1964 | 1 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1964 | 7 | 0.010 |
Why?
|
| Pharmacology | 1 | 1964 | 6 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 162 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1985 | 126 | 0.010 |
Why?
|
| Pregnancy in Diabetics | 1 | 1964 | 8 | 0.010 |
Why?
|
| Pregnancy, Animal | 1 | 1964 | 15 | 0.010 |
Why?
|
| Appetite | 2 | 2002 | 21 | 0.010 |
Why?
|
| Heparin | 1 | 1964 | 39 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1964 | 23 | 0.010 |
Why?
|
| Phototherapy | 1 | 1984 | 25 | 0.010 |
Why?
|
| Physiology | 1 | 1964 | 17 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2003 | 19 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1964 | 110 | 0.010 |
Why?
|
| Seasons | 1 | 1984 | 133 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1964 | 93 | 0.010 |
Why?
|
| Tryptophan | 1 | 1983 | 66 | 0.010 |
Why?
|
| Physical Exertion | 2 | 1974 | 27 | 0.010 |
Why?
|
| Research | 1 | 1964 | 177 | 0.010 |
Why?
|
| Heart | 1 | 1964 | 181 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2001 | 7 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2001 | 55 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 6490 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1964 | 531 | 0.010 |
Why?
|
| Catecholamines | 2 | 1970 | 45 | 0.010 |
Why?
|
| Stress, Psychological | 2 | 1974 | 641 | 0.010 |
Why?
|
| Hormones | 1 | 1976 | 56 | 0.010 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1974 | 4 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1974 | 65 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1974 | 16 | 0.010 |
Why?
|
| Caffeine | 1 | 1974 | 28 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1974 | 98 | 0.010 |
Why?
|
| Biological Assay | 1 | 1974 | 63 | 0.010 |
Why?
|
| Sports | 1 | 1974 | 53 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1973 | 34 | 0.010 |
Why?
|
| Food Preferences | 1 | 1973 | 73 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1974 | 170 | 0.010 |
Why?
|
| Renal Aminoacidurias | 2 | 1961 | 2 | 0.010 |
Why?
|
| Pulmonary Heart Disease | 2 | 1961 | 2 | 0.010 |
Why?
|
| Growth | 2 | 1961 | 11 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1971 | 7 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1974 | 319 | 0.010 |
Why?
|
| Carbonates | 1 | 1970 | 4 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1970 | 4 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1970 | 26 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 2 | 1961 | 78 | 0.010 |
Why?
|
| Vanilmandelic Acid | 1 | 1970 | 1 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1970 | 2 | 0.010 |
Why?
|
| MMPI | 1 | 1970 | 11 | 0.010 |
Why?
|
| Psychophysiology | 1 | 1970 | 14 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 1970 | 63 | 0.000 |
Why?
|
| Behavior | 1 | 1970 | 34 | 0.000 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1970 | 36 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1970 | 76 | 0.000 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1969 | 27 | 0.000 |
Why?
|
| Cholesterol | 1 | 1970 | 230 | 0.000 |
Why?
|
| Anxiety | 2 | 1975 | 847 | 0.000 |
Why?
|
| Diet | 1 | 1971 | 810 | 0.000 |
Why?
|
| Administration, Oral | 2 | 1976 | 256 | 0.000 |
Why?
|
| Phentolamine | 1 | 1964 | 1 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1964 | 2 | 0.000 |
Why?
|
| Basal Metabolism | 1 | 1964 | 6 | 0.000 |
Why?
|
| Pheochromocytoma | 1 | 1964 | 12 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1964 | 25 | 0.000 |
Why?
|
| Delta Rhythm | 1 | 1984 | 1 | 0.000 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 1984 | 7 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1964 | 30 | 0.000 |
Why?
|
| Hyperphagia | 1 | 1984 | 15 | 0.000 |
Why?
|
| Sleep | 1 | 1984 | 179 | 0.000 |
Why?
|
| Amines | 1 | 1961 | 40 | 0.000 |
Why?
|
| Rats | 1 | 1964 | 3701 | 0.000 |
Why?
|
| Psychomotor Disorders | 1 | 1975 | 9 | 0.000 |
Why?
|
| Fasting | 1 | 1975 | 56 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1973 | 21 | 0.000 |
Why?
|
| Neoplasms | 1 | 1964 | 1341 | 0.000 |
Why?
|
| Thioridazine | 1 | 1971 | 1 | 0.000 |
Why?
|
| Trifluoperazine | 1 | 1971 | 5 | 0.000 |
Why?
|
| Imipramine | 1 | 1971 | 9 | 0.000 |
Why?
|
| Social Isolation | 1 | 1971 | 34 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1971 | 56 | 0.000 |
Why?
|
| Pituitary-Adrenal System | 1 | 1969 | 41 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1969 | 55 | 0.000 |
Why?
|